Could a bad mood or infection trigger a major stroke? scientists investigate
NCT ID NCT06265155
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to identify short-term triggers of acute ischemic stroke caused by large vessel occlusion, a severe type of stroke. Researchers will ask 302 patients about their exposure to potential triggers—such as infection, mood changes, smoking, alcohol, diarrhea, and extreme temperatures—in the year before their stroke and just before it happened. By comparing these time periods, they hope to pinpoint which factors may increase stroke risk in the hours or days prior.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify specific triggers that raise the short-term risk of severe stroke, helping people avoid them and potentially reducing stroke incidence.
- What could go wrong
- This is an observational study, not a treatment trial. It can only suggest associations, not prove cause and effect. Recall bias may affect results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE DUE TO LARGE VESSEL OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Suzhou Hospital Anhui Medical University
Suzhou, Anhui, 234000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Balloon trick after clot removal may shield the brain
- Can pressurized oxygen boost stroke recovery?
- Stroke neuroprotection trial pulled before it started
- Stroke hope: clot removal may work even days later
- New device aims to clear stroke clots faster and safer
- Experimental stroke drug RNS60 passes early safety check in small trial